| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10835758 | Peptides | 2011 | 6 Pages |
Abstract
⺠The effects of the bradykinin B1 antagonist R-954 were evaluated on the inflammatory reaction associated with the progression of Ehrlich ascitic tumor in mice and rats. ⺠R-954 reduced the inflammatory mediators, tumor growth as well as total cell numbers in medulla, blood, and ascitic fluid which follow the tumor inoculation. ⺠R-954 also inhibited the increase of solid tumor inoculated in rat paw.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Patricia Dias Fernandes, Niele de Matos Gomes, Pierre Sirois,